Revvity | PKI - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agilent USD 1.44B 9M 2026-03
Align Technology USD 864.87M 2.84M 2026-06
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Celltrion KRW 119.22B 21.46B 2026-03
Charles River Laboratories USD 2.84B 1.96B 2026-06
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
Illumina USD 899M 47M 2026-06
Intuitive Surgical USD 1.91B 3.6M 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.27B 146.9M 2026-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 739.77M 26.57M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 173K 990K 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pharma Mar EUR 51.01M 8.73M 2026-06
Qiagen NV USD 375.69M 42.85M 2026-03
Quest Diagnostics USD 2.58B 88M 2026-06
Quidel USD 646.2M 1.21B 2026-06
Repligen USD 183M 8.72M 2026-06
Revvity USD 603.55M 24.8M 2026-06
Sartorius EUR 747.8M 9.4M 2026-06
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Tilray USD 237.52M 17.34M 2025-09
Waters USD 527M 592M 2026-06
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03